Advisory Committee on Immunization Practices(ACIP) approves inclusion of Medigen COVID-19 vaccine as an option for national vaccine rollout and allows mRNA vaccine to be used as a second dose after a first dose of AstraZeneca vaccine-Crucial Policy for Combating COVID-19

press enter to main content

Advisory Committee on Immunization Practices(ACIP) approves inclusion of Medigen COVID-19 vaccine as an option for national vaccine rollout and allows mRNA vaccine to be used as a second dose after a first dose of AstraZeneca vaccine

font：

S
M
L

Back
Print

See the Taiwan CDC website for the latest news on COVID-19：https://www.cdc.gov.tw/En

Created：2021-07-25
Last Updated：2021-08-11
Count Views：